The therapeutic potential of immune therapy in idiopathic dilated cardiomyopathy

ISSN： 1479-6678

Source： Future Cardiology, Vol.1, Iss.5, 2005-09, pp. : 675-682

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Defining the Molecular Genetic Basis of Idiopathic Dilated Cardiomyopathy

By Olson T.M. Keating M.T.

Trends in Cardiovascular Medicine, Vol. 7, Iss. 2, 1997-02 ,pp. : 60-63

Elsevier

Access to resources Recommend Favorite

Antioxidative Enzymes in Human Hearts with Idiopathic Dilated Cardiomyopathy

By Bäumer A.T. Flesch M. Wang X. Shen Q. Feuerstein G.Z. Böhm M.

Journal of Molecular and Cellular Cardiology, Vol. 32, Iss. 1, 2000-01 ,pp. : 121-130

Academic Press

Access to resources Recommend Favorite

Multiple Sclerosis with Idiopathic Dilated Cardiomyopathy: A Case Report

European Neurology, Vol. 53, Iss. 4, 2005-07 ,pp. : 214-215

Karger

Access to resources Recommend Favorite

Dilated cardiomyopathy update: infectious-immune theory revisited

By Kawai Chuichi Matsumori Akira

Heart Failure Reviews, Vol. 18, Iss. 6, 2013-11 ,pp. : 703-714

Springer Publishing Company

Access to resources Recommend Favorite

Is atrial function in Chagas dilated cardiomyopathy more impaired than in idiopathic dilated cardiomyopathy?

By Barbosa Marcia M. Rocha Manoel Otávio C. Botoni Fernando Antônio Ribeiro Antônio Luiz Pinho Nunes Maria Carmo Pereira

European Journal of Echocardiography, Vol. 12, Iss. 9, 2011-09 ,pp. : 643-647

Oxford University Press

Access to resources Recommend Favorite